Immunomedics Broke Exit Deal With Founder, Chancery Told

By Jeff Montgomery · March 19, 2021, 8:07 PM EDT

An attorney for the scientist-founder and former chairman of a company acquired last year by Gilead Sciences for $21 billion told a Delaware vice chancellor on Friday that Immunomedics Inc. was...

To view the full article, register now.